Condition
s Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 7 s Syndrome clinical trials that are recruiting, at sites in 3 countries (most in China (5), United States (1), Denmark (1)). By phase: Phase 1 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 3Countries
Newest s Syndrome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BCMA/CD70-directed CAR-T for children with hard-to-treat rheumatic diseases | Phase 1 | Hangzhou, Zhejiang | Recruiting | Sep 19, 2025 |
| OL-CD19-GDT CAR‑T for relapsed or refractory systemic sclerosis and primary Sjögren's syndrome | Phase 1 | Beijing | Recruiting | Sep 11, 2025 |
| YTS109 cell therapy for relapsed or refractory systemic autoimmune diseases | Phase 1 | Beijing, Beijing Municipality | Recruiting | May 18, 2025 |
| A system for diagnosing and treating children's brain diseases using advanced technology | — | Nanjing | Recruiting | Feb 27, 2025 |
| Treatment for dry mouth using stem cells in Sjögren's Syndrome patients | Phase 1/2 | Copenhagen | Recruiting | Feb 3, 2025 |
| Using engineered immune cells to treat difficult autoimmune diseases | — | Hangzhou, Zhejiang | Recruiting | Sep 26, 2024 |
| A platform for collecting health data on ME/CFS and Long Covid | — | Delafield, Wisconsin | Recruiting | Mar 19, 2021 |
All recruiting trials (7)
-
BCMA/CD70-directed CAR-T for children with hard-to-treat rheumatic diseases
This trial will try a BCMA/CD70-directed CAR-T therapy in children aged 5 and older whose rheumatic diseases have not responded to standard treatments.
-
OL-CD19-GDT CAR‑T for relapsed or refractory systemic sclerosis and primary Sjögren's syndrome
This trial will try the CAR‑T therapy OL‑CD19‑GDT in adults whose systemic sclerosis or primary Sjögren's syndrome has relapsed or not responded to other treatments to see if it is safe and helps.
-
YTS109 cell therapy for relapsed or refractory systemic autoimmune diseases
This trial will try a single infusion of YTS109 cells to see if it's safe and helps adults 18–65 with relapsed or refractory systemic autoimmune diseases such as SLE, systemic sclerosis, inflammatory myopathies, ANCA-associated vasculitis, or antiphospholipid syndrome.
-
A system for diagnosing and treating children's brain diseases using advanced technology
This study is testing a new system that uses advanced technology to help doctors diagnose and treat different brain diseases in children, like ADHD and autism, by combining ideas from both Chinese and Western medicine.
-
Treatment for dry mouth using stem cells in Sjögren's Syndrome patients
This study is testing whether injections of stem cells can help people with Sjögren's Syndrome who have dry mouth feel better and produce more saliva.
-
Using engineered immune cells to treat difficult autoimmune diseases
This study is testing if a new type of immune cell treatment can help people with tough autoimmune diseases that haven't responded to other therapies.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
Related topics
Quick answers
How many s Syndrome clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (5 trials), United States (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.